NYSE · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP
Centene Corporation CNC
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$174.6B
▲ 20.0% vs FY2024
EPS · FY25
$-13.53
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-28.8%
Net margin · FY25
-3.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 174.6B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
The company lost 4 cents on every revenue dollar this year.
Per share
USD -13.53
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-28.8%
Return on equity, FY2025
ROE
Operating margin-4.4%
Net margin-3.8%
Return on assets-8.4%
Each USD of equity lost 29 cents this year.
Returned to shareholders
USD 438.0M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 438.0M
Share of profit-6.6%
Consecutive raises—
USD 438.0M in buybacks went back to shareholders in a year without profit.
Growth
+11.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+8.8%
+11.0%
+22.6%
+27.7%
Returned to shareholders
−47.5%
−6.0%
+27.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.49B
Shares outstanding, FY2025
Change, 5 years−15.4%
Change, 10 years—
The share count shrank 15% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 76.7B
total assets, end of FY2025
Total assetsUSD 76.7B
EquityUSD 20.0B
CashUSD 17.9B
Gross debtUSD 17.4B
Net debtUSD -487.0M
Current ratio1.10×
The company holds more cash than debt.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
174.6
145.5
140.1
135.5
118.0
103.8
70.4
56.4
45.6
37.6
22.8
16.6
10.9
8.1
5.2
4.4
4.1
3.4
Operating income $B
−7.6
3.2
2.9
1.3
1.8
3.1
1.8
1.5
1.2
1.3
0.7
0.5
0.3
0.1
0.2
0.2
0.1
0.1
EBITDA $B
−7.0
3.7
3.5
1.9
2.3
3.6
2.1
1.7
1.4
1.4
0.8
0.5
0.3
0.2
0.2
0.2
0.2
·
Income tax $B
−0.1
1.0
0.9
0.8
0.5
1.0
0.5
0.5
0.3
0.6
0.3
0.2
0.1
0.0
0.1
0.1
0.0
0.1
Net income $B
−6.7
3.3
2.7
1.2
1.3
1.8
1.3
0.9
0.8
0.6
0.4
0.3
0.2
0.0
0.1
0.1
0.1
0.1
EPS, diluted $
−13.53
6.31
4.95
2.07
2.28
3.12
3.14
2.26
2.34
1.71
2.88
2.25
1.47
0.02
2.12
1.88
1.89
1.88
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−28.8
12.7
10.8
4.7
5.1
9.4
11.3
10.1
13.0
14.0
18.2
18.2
15.1
0.2
12.9
13.6
13.9
·
Shares out B
0.49
0.50
0.53
0.55
0.58
0.58
0.42
0.41
0.35
0.17
0.12
0.12
0.11
0.05
0.05
0.05
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
52 of 57
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 5 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed